Bloomberg IntelligenceBloomberg Intelligence

GW's Gover on Cannabis-Derived Drug for Rare Epilepsy (Audio)

View descriptionShare

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Justin Gover, CEO of GW Pharmaceuticals, on the drug pipeline for the UK- based company which has been developing drug treatments derived from cannabis for decades.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Bloomberg Intelligence

    3,286 clip(s)

Bloomberg Intelligence

Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and p 
Social links
Follow podcast
Recent clips
Browse 3,282 clip(s)